PMID-16635254 – Semax Binds and Increases BDNF in Rat Basal Forebrain
Dolotov OV et al., "Semax, an analogue of ACTH(4-10) with cognitive effects, regulates BDNF and trkB in the rat hippocampus," J Neurochem, 2006;97(Suppl 1):19-26. DOI: 10.1111/j.1471-4159.2006.03658.x
Quick Reference
| Property | Value |
|---|---|
| PMID | 16635254 |
| DOI | 10.1111/j.1471-4159.2006.03658.x |
| Year | 2006 |
| Journal | Journal of Neurochemistry |
| Study Type | Animal in vivo / In vitro |
| Evidence Level | V |
| Sample | Rat brain tissue (basal forebrain, cerebellum) |
| Peptide(s) Studied | Semax |
Key Findings
- Intranasal administration of Semax significantly increased BDNF protein levels in the rat basal forebrain within 3 hours of treatment.
- Specific calcium-dependent binding sites for Semax were identified in basal forebrain tissue, suggesting a direct receptor-mediated mechanism.
- The BDNF-enhancing effect was region-specific: robust increases were observed in the basal forebrain but not in the cerebellum, indicating selective neurotrophin modulation.
Study Design
Combined in vivo intranasal Semax administration in rats with in vitro binding assays on dissected brain tissue. BDNF protein levels were measured by immunoassay at multiple time points post-administration. Calcium-dependent binding was assessed using radiolabeled peptide binding to membrane fractions from different brain regions.
Limitations
- Animal model only; direct translation to human BDNF modulation is uncertain.
- Limited brain regions examined; effects in other critical areas (e.g., prefrontal cortex, amygdala) were not assessed.
Clinical Relevance
This study provides mechanistic support for Semax's cognitive-enhancing properties by demonstrating direct BDNF upregulation in a brain region critical for cholinergic signaling and memory, strengthening the rationale for its use in cognitive enhancement and neuroprotection protocols.
Related
#research #animal-in-vivo #evidence-level-V